oncology

The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.

They have so far developed AI prediction models for breast, colon, and lung cancers.

They will provide the first access to an AI-enabled minimal residual disease test in India.

If patients reported severe or worsening symptoms, their care teams were alerted.

Also: Precision oncology platform OncoHost scores $35 million, home care startup Reverence emerges from stealth with $9.5 million and pediatric behavioral health startup Handspring Health completes a $6.2 million seed round.

MFine users can now book tests from Datar Cancer Genetics.

The company helps patients find clinical trials and works with pharma companies to limit barriers to enrollment.

Also: League scores $95 million, Jasper Health raises $25 million and Summus Global rakes in $22 million.

The startup plans to use the funds to develop its platform, launch a virtual care center and expand its care team.

The partnership aims to investigate the role genetics play in developing personalised cancer treatments